NAVD real-world outcomes #lymsm
- 327 pts, med age 37, 24% ≥60 yrs
- ORR 94% (CR 86%)
- 1-yr PFS 94.5%, OS 99.7%
- irAEs in 29% (9% G3+)
- febrile neutropenia 10%, infections 25% (10% G3+)
RW efficacy mirrors S1826, tho notably⬆️ infections (despite GCSF) & irAEs.
pmc.ncbi.nlm.nih.gov/articles/PMC...
